Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2026 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkorAcceptable Use
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to Reports
Fundraising

Estée Lauder

Estée Lauder Raises $100B in Public

767 Fifth Avenue, New York, NY 10153January 1, 20242 min read
Employees
62000+

Estée Lauder Raises $100B in Public


Estée Lauder has successfully raised $100B in a Public at a $110B valuation led by Public.


Company Overview


Estée Lauder is a Consumer Goods company headquartered in 767 Fifth Avenue, New York, NY 10153, founded in 1946 with 62000+ employees.


Cosmetics company


Fundraising Details


  • Amount Raised: $100B
  • Round Type: Public
  • Valuation: $110B
  • Date: 2024-01-01
  • Investors: Public

About Estée Lauder


Cosmetics company The company is positioned in the Consumer Goods sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 767 Fifth Avenue, New York, NY 10153
  • Founded: 1946
  • Team Size: 62000+
  • Industry: Consumer Goods

What This Means


This funding round demonstrates strong investor confidence in Estée Lauder's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Consumer Goods sector continues to attract significant investment as companies innovate to meet evolving market demands. Estée Lauder's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $110B valuation marks an important milestone for Estée Lauder, positioning the company among notable players in the Consumer Goods industry.


Looking Ahead


With this new capital, Estée Lauder is well-positioned to execute on its growth strategy and continue building innovative solutions in the Consumer Goods space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Estée Lauder, visit their headquarters at 767 Fifth Avenue, New York, NY 10153.

Company Info

Headquarters
767 Fifth Avenue, New York, NY 10153
Founded
1946
Team Size
62000+

Topics

Fundraising(2912)Public(771)Consumer GoodsEstée Lauder

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free